DISTONOCALM 0.2mg / 0.3mg / 15mg / 25mg film-coated tablets medication leaflet

C07NAN1 atropine sulfate + ergoton + propranolol + amobarbital sodium • Cardiovascular system |

This combination of atropine sulfate, ergoton, propranolol, and sodium amobarbital is used for the treatment of severe migraines and other vascular disorders. Atropine sulfate reduces muscle spasms, ergoton improves vascular tone, propranolol lowers heart rate, and amobarbital has a sedative effect.

The medication is administered orally or by injection, as directed by a doctor. It is important for patients to follow the prescribed dosage and avoid alcohol consumption during treatment.

Patients should be aware of potential side effects, such as drowsiness, dizziness, or nausea. It is important to inform the doctor of any unusual symptoms.

Common side effects include drowsiness, dizziness, nausea, and dry mouth. In rare cases, severe reactions such as respiratory depression or allergic reactions may occur. Patients should be informed of these risks before starting treatment.

General data about DISTONOCALM 0.2mg / 0.3mg / 15mg / 25mg

Substance: atropine sulfate + ergoton + propranolol + amobarbital sodium

Date of last drug list: 01-01-2019

Commercial code: W52430002

Concentration: 0.2mg / 0.3mg / 15mg / 25mg

Pharmaceutical form: film-coated tablets

Quantity: 30

Product type: original

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.